Evaluation of the IRAK2 and IRAK3 Pseudokinases as Targets for Novel Drugs to Treat Inflammatory Diseases (Industrial CASE Studentship)

Project Details

StatusFinished
Effective start/end date14/09/15 → 30/09/19

Funding

  • (PhD-770-2014): £110,000.00